|
|
| (2 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| {{DISPLAYTITLE:Acute myeloid leukaemia with BCR::ABL1 fusion}} | | {{DISPLAYTITLE:Acute myeloid leukaemia with BCR::ABL1 fusion}} |
| | |
| [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] |
|
| |
|
| Line 34: |
Line 35: |
| |} | | |} |
|
| |
|
| ==WHO Essential and Desirable Genetic Diagnostic Criteria==
| |
| {| class="wikitable"
| |
| |+
| |
| |WHO Essential Criteria (Genetics)*
| |
| |a myeloid neoplasm with >20% blasts expressing a myeloid immunophenotype in the bone marrow and/or peripheral blood; detection of ''BCR::ABL1'' at initial diagnosis; lack of features of chronic myeloid leukaemia (CML) before or at diagnosis or after therapy.
| |
| |-
| |
| |WHO Desirable Criteria (Genetics)*
| |
| |presence of t(9;22)(q34;q11.2) on conventional karyotyping; determination of the ''BCR::ABL1'' transcript subtype and establishment of a baseline level of ''BCR::ABL1'' transcript subtype and establishment of a baseline level of ''BCR::ABL1'' transcript for monitoring treatment response.
| |
| |-
| |
| |Other Classification
| |
| |
| |
| |}
| |
| <nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>].
| |
| ==Related Terminology== | | ==Related Terminology== |
|
| |
|
